DE3868821D1 - Fuer mindestens einzellige lebewesen inhibitierende oder zerstoerende f- und li+ enthaltende zusammensetzung. - Google Patents

Fuer mindestens einzellige lebewesen inhibitierende oder zerstoerende f- und li+ enthaltende zusammensetzung.

Info

Publication number
DE3868821D1
DE3868821D1 DE8888402358T DE3868821T DE3868821D1 DE 3868821 D1 DE3868821 D1 DE 3868821D1 DE 8888402358 T DE8888402358 T DE 8888402358T DE 3868821 T DE3868821 T DE 3868821T DE 3868821 D1 DE3868821 D1 DE 3868821D1
Authority
DE
Germany
Prior art keywords
composition
inhibitating
destructive
cell
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888402358T
Other languages
English (en)
Inventor
Pierre Bourbon
Pierre Lagny
Pierre Billot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aromafarm Ltd
Original Assignee
Atlantic Pharmaceutical Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlantic Pharmaceutical Products Ltd filed Critical Atlantic Pharmaceutical Products Ltd
Application granted granted Critical
Publication of DE3868821D1 publication Critical patent/DE3868821D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/10—Fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DE8888402358T 1987-09-22 1988-09-19 Fuer mindestens einzellige lebewesen inhibitierende oder zerstoerende f- und li+ enthaltende zusammensetzung. Expired - Fee Related DE3868821D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713086A FR2620620B1 (fr) 1987-09-22 1987-09-22 Substance inhibitrice ou destructrice d'au moins un etre vivant unicellulaire renfermant du fluor f- et du lithium li+

Publications (1)

Publication Number Publication Date
DE3868821D1 true DE3868821D1 (de) 1992-04-09

Family

ID=9355110

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888402358T Expired - Fee Related DE3868821D1 (de) 1987-09-22 1988-09-19 Fuer mindestens einzellige lebewesen inhibitierende oder zerstoerende f- und li+ enthaltende zusammensetzung.

Country Status (11)

Country Link
US (1) US5063064A (de)
EP (1) EP0310476B1 (de)
JP (1) JP2777148B2 (de)
AT (1) ATE72983T1 (de)
CA (1) CA1341359C (de)
DE (1) DE3868821D1 (de)
ES (1) ES2034326T3 (de)
FR (1) FR2620620B1 (de)
GR (1) GR3004840T3 (de)
IL (1) IL87828A0 (de)
MC (1) MC1977A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662941A (en) * 1987-09-22 1997-09-02 Bourbon; Pierre Method for treating diseases caused by bacterial microorganisms with a composition containing fluorine F- and lithium LI+
JPH01135704A (ja) * 1987-11-18 1989-05-29 Medical Res Internatl Ltd 微生物を破壊する表面処理方法
GB2311222A (en) * 1996-03-18 1997-09-24 Mary Viktoria Kelemen Cold sterilant composition comprising an aqueous solution of lithium iodide and iodine
WO1999027361A1 (en) * 1997-11-20 1999-06-03 Esa, Inc. Electrochemical analysis system
AU3367799A (en) 1998-03-30 1999-10-18 Esa Inc. Methodology for predicting and/or diagnosing disease
ES2164018B1 (es) * 2000-05-26 2003-06-16 Inst De Salud Carlos Iii Empleo de una sal de litio en la elaboracion de un medicamento para el tratamiento de la infeccion causada por el virus respiratorio sincitial humano (vrdh)
EP2359690A1 (de) 2010-02-23 2011-08-24 East Coast Pharmaceutical Research LLC Vervielfachung der Wirksamkeit von Antiinfektiosa mittels einer Zusammensetzung, die gleichzeitig ein Dispergiermittel und ein Metallaktivierungsmittel umfasst
EP2982247A1 (de) * 2014-08-07 2016-02-10 Omya International AG Antiseptisches Produkt, Verfahren zur Herstellung und dessen Verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
US4321277A (en) * 1978-12-04 1982-03-23 Research Lab Products, Inc. Germicidal use of compositions containing certain quaternary ammonium compounds
JPS57131714A (en) * 1980-12-24 1982-08-14 Warner Lambert Co Caries controlling method and composition
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions
US4568540A (en) * 1984-04-18 1986-02-04 Johnson & Johnson Oral hygiene compositions
DE3543801A1 (de) * 1985-12-12 1987-06-25 Marquardt Bernd Pharmazeutisches produkt enthaltend ein gemisch aus benzoesaeure, phenol und ein alkalifluorid in waessriger oder waessrig-alkoholischer loesung und seine verwendung
ATE64854T1 (de) * 1986-05-22 1991-07-15 Atlantic Pharma Prod Zusammensetzung mit hemmender wirkung auf zumindest ein einzelliges lebewesen und/oder virus, herstellungsverfahren und anwendungen dieser zusammensetzung.

Also Published As

Publication number Publication date
JPH01163126A (ja) 1989-06-27
GR3004840T3 (de) 1993-04-28
EP0310476B1 (de) 1992-03-04
EP0310476A1 (de) 1989-04-05
FR2620620B1 (fr) 1991-04-05
US5063064A (en) 1991-11-05
CA1341359C (fr) 2002-05-21
ATE72983T1 (de) 1992-03-15
ES2034326T3 (es) 1993-04-01
MC1977A1 (fr) 1989-11-23
FR2620620A1 (fr) 1989-03-24
JP2777148B2 (ja) 1998-07-16
IL87828A0 (en) 1989-03-31

Similar Documents

Publication Publication Date Title
ES554573A0 (es) Procedimiento para la produccion de un articulo elastomerico contenedor de un agente biologica o no biologicamente activo
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
IL114447A0 (en) Multiple unit pharmaceutical preparation
AU6279996A (en) Methods of delivering materials into the skin, and compositions used therein
AU2046688A (en) Prophylactic device made of elastomeric material, such as a contraceptive sheath or the like, and process for its manufacture
FI956310A (fi) Stabiloidut farmaseuttiset peptidikoostumukset
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
MA21182A1 (fr) Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant.
GR3006177T3 (de)
DE3868821D1 (de) Fuer mindestens einzellige lebewesen inhibitierende oder zerstoerende f- und li+ enthaltende zusammensetzung.
BR8302478A (pt) Composicao homogenea pesticida liquida,metodo de tratamento de sementes e metodo de combate as pragas de fungos sobre folhagem de plantas
EP0156275A3 (en) Antimicrobially active substances, their preparation and their use
ATE279112T1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
TW264386B (de)
MY100936A (en) Pesticidal compositions and process for preparation thereof
SE8404065D0 (sv) Novel biologically active compounds
CA2031817A1 (en) Use of thrombospondin to promote wound healing
ES2063051T3 (es) Cepas bacterianas.
AU4538489A (en) Pharmaceutical compositions
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
DE69624343T2 (de) Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten
ES451188A1 (es) Un procedimiento para la preparacion de nuevas poliaminas.
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
Garg et al. Efficacy of co-trimoxazole in Donovanosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AROMAFARM LTD., CASTLETOWN, ISLE OF MAN, GB

8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee